Elhízás: vizsgálatok itt: Törökország
17 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Adana, Ankara, Antalya, Istanbul, Izmir, Sariçam
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Ankara, Antalya, Center, Istanbul
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - No phaseTaking peopleWhole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
- Where
- Denizli
- Életkor
- 18 év to 65 év
- People
- 30
- Run by
- Pamukkale University
See details and how to joinNCT07924436 - No phaseTaking peopleOcular Changes in Patients Using Tirzepatide or Semaglutide
- Where
- Istanbul
- Életkor
- 18 év and over
- People
- 40
- Run by
- Istanbul University
See details and how to joinNCT07924618 - No phaseTaking peopleTwo-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With Obesity
- Where
- Van
- Életkor
- 18 év and over
- People
- 200
- Run by
- Yuzuncu Yil University
See details and how to joinNCT07901777 - 3. fázisTaking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Ankara, Antalya, Bursa, Eskişehir, Hatay, Istanbul, Izmir, İzmit, Mersin
- Életkor
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - 3. fázisTaking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Ankara, Bursa, Eskişehir, Hatay, Istanbul, Izmir, İzmit, Mersin, Muratpaşa
- Életkor
- 18 év to 70 év
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - 3. fázisNot yet taking people in TörökországA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Adana, Ankara, Antalya, Diyarbakır, Eskişehir, Istanbul, Kayseri, Kocaeli, Yüreğir
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Adana, Afyonkarahisar, Ankara, Çorum, Eskişehir, Istanbul, Izmir, Kayseri, Kocaeli, Konya
- Életkor
- 18 év to 99 év
- People
- 5056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - 3. fázisTaking peopleA Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults
- Where
- Ankara, Kayseri
- Életkor
- 2 év and over
- People
- 4 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07220772 · EU 2024-518674-14-00 - 3. fázisTaking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Adana, Adapazarı, Ankara, Antalya, Istanbul
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - 3. fázisTaking peopleAMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Where
- Alanya/ Antalya, Maltepe/İstanbull, Merkez/Battalgazi/Malatya, Merkez/Çorum, Yenimahalle / Ankara, Yıldırım/Bursa, Yuregir/Adana, Zeytinburnu/İstanbul
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07571109 · EU 2024-520443-16-00 - 3. fázisTaking peopleAMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Where
- Alanya/ Antalya, Maltepe/İstanbull, Merkez/Battalgazi/Malatya, Merkez/Çorum, Yenimahalle / Ankara, Yıldırım/Bursa, Yuregir/Adana, Zeytinburnu/İstanbul
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07571005 · EU 2024-520442-36-00 - 3. fázisTaking peopleA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Adana, Adapazarı/Sakarya, Afyonkarahisar, Altınordu/Ordu, Ankara, Antalya, Bayraklı/İzmir, Bursa, Çanakkale/Türkiye, Canik/Samsun, Eskişehir, Istanbul, Izmir, Kayseri, Keçiören/Ankara, Kocaeli, Kütahya, Malatya, Merkez/elaziğ, Mersin, Muratpasa/ Antalya, Yakutiye / Erzurum, Yenimahalle/Ankara, Yuregir/Adana
- Életkor
- 18 év and over
- People
- 5610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00 - 3. fázisTaking peopleAMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Where
- Bahçelievler/İstanbul, Çankaya/Ankara, Edirne, Fatih/İstanbul, Yıldırım/Bursa, Yuregir/Adana
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07509307 · EU 2024-520445-23-00 - No phaseTaking peopleUNMASK: Unveiling the Pathobiology of Metabolic Dysfunction-Associated Steatotic Liver Disease for the Discovery of Novel Therapeutics and Biomarkers
- Where
- Ankara
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
See details and how to joinNCT07652151 - 2. fázisTaking peopleA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- Where
- Adana, Ankara, Gaziantep, Istanbul, Izmir, Kayseri, Kocaeli
- Életkor
- 18 év and over
- People
- 465 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00